Viewing Study NCT00112060


Ignite Creation Date: 2025-12-25 @ 2:05 AM
Ignite Modification Date: 2026-05-23 @ 7:35 AM
Study NCT ID: NCT00112060
Status: WITHDRAWN
Last Update Posted: 2014-03-31
First Post: 2005-05-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Safety and Preliminary Efficacy of PT-523 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
Sponsor: Spectrum Pharmaceuticals, Inc
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: HBS101
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators